FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
Date Action Amount Person Type
Jan 02, 2024 Sell 11 000 Patel Anish Common Stock
Jan 02, 2024 Sell 9 383 Hohl Benjamin Employee Stock Option (right to buy)
Jan 02, 2024 Buy 9 383 Hohl Benjamin Common Stock
Jan 02, 2024 Sell 9 383 Hohl Benjamin Common Stock
Dec 29, 2023 Sell 12 000 Lyssikatos Joseph P Stock Option (right to buy)
Dec 29, 2023 Buy 12 000 Lyssikatos Joseph P Common Stock
Dec 29, 2023 Sell 9 151 Lyssikatos Joseph P Common Stock
Dec 29, 2023 Sell 2 849 Lyssikatos Joseph P Common Stock
Dec 29, 2023 Sell 20 Patel Anish Common Stock
Dec 29, 2023 Sell 20 Hohl Benjamin Employee Stock Option (right to buy)
Dec 29, 2023 Buy 20 Hohl Benjamin Common Stock
Dec 29, 2023 Sell 20 Hohl Benjamin Common Stock
Dec 28, 2023 Sell 2 520 Patel Anish Common Stock
Dec 28, 2023 Sell 2 467 Hohl Benjamin Employee Stock Option (right to buy)
Dec 28, 2023 Buy 2 467 Hohl Benjamin Common Stock
Dec 28, 2023 Sell 2 467 Hohl Benjamin Common Stock
Dec 26, 2023 Sell 12 000 Kintz Samuel Stock Option (right to buy)
Dec 26, 2023 Buy 12 000 Kintz Samuel Common Stock
Dec 26, 2023 Sell 12 000 Kintz Samuel Common Stock
Dec 26, 2023 Sell 102 Patel Anish Common Stock
Dec 26, 2023 Sell 100 Hohl Benjamin Employee Stock Option (right to buy)
Dec 26, 2023 Buy 100 Hohl Benjamin Common Stock
Dec 26, 2023 Sell 100 Hohl Benjamin Common Stock
Dec 22, 2023 Sell 983 Patel Anish Common Stock
Dec 22, 2023 Sell 1 030 Hohl Benjamin Employee Stock Option (right to buy)
Dec 22, 2023 Buy 1 030 Hohl Benjamin Common Stock
Dec 22, 2023 Sell 1 030 Hohl Benjamin Common Stock
Dec 22, 2023 Sell 6 546 Lyssikatos Joseph P Stock Option (right to buy)
Dec 22, 2023 Buy 6 546 Lyssikatos Joseph P Common Stock
Dec 22, 2023 Sell 6 546 Lyssikatos Joseph P Common Stock
Dec 22, 2023 Sell 8 175 Kintz Samuel Stock Option (right to buy)
Dec 22, 2023 Buy 8 175 Kintz Samuel Common Stock
Dec 22, 2023 Sell 8 175 Kintz Samuel Common Stock
Dec 22, 2023 Sell 168 Heyman Richard A. Common Stock
Dec 22, 2023 Sell 35 Heyman Richard A. Common Stock
Dec 21, 2023 Sell 20 Lyssikatos Joseph P Stock Option (right to buy)
Dec 21, 2023 Buy 20 Lyssikatos Joseph P Common Stock
Dec 21, 2023 Sell 20 Lyssikatos Joseph P Common Stock
Dec 21, 2023 Sell 20 Kintz Samuel Stock Option (right to buy)
Dec 21, 2023 Buy 20 Kintz Samuel Common Stock
Dec 21, 2023 Sell 20 Kintz Samuel Common Stock
Dec 21, 2023 Sell 7 Heyman Richard A. Common Stock
Dec 21, 2023 Sell 6 Heyman Richard A. Common Stock
Dec 20, 2023 Sell 7 779 Kintz Samuel Stock Option (right to buy)
Dec 20, 2023 Buy 7 779 Kintz Samuel Common Stock
Dec 20, 2023 Sell 7 779 Kintz Samuel Common Stock
Dec 20, 2023 Sell 8 688 Lyssikatos Joseph P Stock Option (right to buy)
Dec 20, 2023 Buy 8 688 Lyssikatos Joseph P Common Stock
Dec 20, 2023 Sell 8 688 Lyssikatos Joseph P Common Stock
Dec 20, 2023 Sell 2 110 Heyman Richard A. Common Stock
Dec 20, 2023 Sell 1 915 Heyman Richard A. Common Stock
Dec 19, 2023 Sell 200 Lyssikatos Joseph P Stock Option (right to buy)
Dec 19, 2023 Buy 200 Lyssikatos Joseph P Common Stock
Dec 19, 2023 Sell 200 Lyssikatos Joseph P Common Stock
Dec 19, 2023 Sell 255 Heyman Richard A. Common Stock
Nov 03, 2023 Sell 8 546 Lyssikatos Joseph P Stock Option (right to buy)
Nov 03, 2023 Buy 8 546 Lyssikatos Joseph P Common Stock
Nov 03, 2023 Sell 8 546 Lyssikatos Joseph P Common Stock
Nov 03, 2023 Sell 8 026 Kintz Samuel Stock Option (right to buy)
Nov 03, 2023 Buy 8 026 Kintz Samuel Common Stock
Nov 03, 2023 Sell 8 026 Kintz Samuel Common Stock
Sep 29, 2023 Sell 12 000 Lyssikatos Joseph P Stock Option (right to buy)
Sep 29, 2023 Buy 12 000 Lyssikatos Joseph P Common Stock
Sep 29, 2023 Sell 12 000 Lyssikatos Joseph P Common Stock
Sep 26, 2023 Sell 164 789 5am Partners Vi, Llc Common Stock
Sep 26, 2023 Sell 32 711 5am Partners Vi, Llc Common Stock
Sep 25, 2023 Sell 12 000 Kintz Samuel Stock Option (right to buy)
Sep 25, 2023 Buy 12 000 Kintz Samuel Common Stock
Sep 25, 2023 Sell 12 000 Kintz Samuel Common Stock
Aug 24, 2023 Sell 367 124 5am Partners Vi, Llc Common Stock
Aug 24, 2023 Sell 72 876 5am Partners Vi, Llc Common Stock
May 17, 2023 Buy 2 125 Orbimed Advisors Llc Common Stock
May 17, 2023 Sell 2 125 Orbimed Advisors Llc Stock Options (Right to Buy)
May 17, 2023 Buy 2 125 Gupta Rishi Common Stock
May 17, 2023 Sell 2 125 Gupta Rishi Stock Options (Right to Buy)
Apr 04, 2023 Buy 206 000 Patel Anish Stock Option (right to buy)
Apr 04, 2023 Buy 206 000 Lyssikatos Joseph P Stock Option (right to buy)
Apr 04, 2023 Buy 206 000 Hohl Benjamin Stock Option (right to buy)
Apr 04, 2023 Buy 206 000 Collins Helen Louise Stock Option (right to buy)
Apr 04, 2023 Buy 452 000 Kintz Samuel Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Schwab Andrew J. Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Phillips Andrew John Stock Option (right to buy)
Feb 23, 2023 Buy 34 458 Heyman Richard A. Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Gupta Rishi Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Derynck Mika K Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Bauer Jake Stock Option (right to buy)
Feb 23, 2023 Buy 27 567 Ballal Rahul D. Stock Option (right to buy)
Feb 23, 2023 Buy 0 5am Partners Vi, Llc Common Stock
Feb 23, 2023 Buy 0 5am Partners Vi, Llc Common Stock
Feb 23, 2023 Buy 4 838 092 Schwab Andrew J. Common Stock
Feb 23, 2023 Buy 960 383 Schwab Andrew J. Common Stock
Feb 23, 2023 Buy 149 820 Heyman Richard A. Common Stock
Feb 23, 2023 Buy 37 407 Heyman Richard A. Common Stock
Feb 23, 2023 Buy 31 172 Heyman Richard A. Common Stock
Feb 23, 2023 Buy 20 657 Heyman Richard A. Employee Stock Option (right to buy)
Feb 23, 2023 Buy 0 Heyman Richard A.
Feb 23, 2023 Buy 7 611 458 Gupta Rishi Common Stock
Feb 23, 2023 Buy 288 114 Gupta Rishi Common Stock
Feb 23, 2023 Buy 87 372 Bauer Jake Common Stock
Feb 23, 2023 Buy 17 706 Bauer Jake Stock Option
INSIDER POWER
65.548
Last 100 transactions
Buy: 15 631 291 | Sell: 878 871 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 65.548.

In total, the insiders bought 15 631 291 and sold 878 871 IMRA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About IMARA Inc.

IMARA. IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for th... IMRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT